Linfeng Xu

Screening Active Compounds from Garcinia Species Native to China Reveals Novel Compounds Targeting the STAT/JAK Signaling Pathway

Y. Lao, Yingjia Zhang, Yanhui Zhao, 2015, BioMed research international.

Functions of non-coding RNAs in regulating cancer drug targets

Zhongliang Ma, Yanli Li, Xianyi Wang, 2022, Acta biochimica et biophysica Sinica.

Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer

Wenhui Zhang, Hua Zhou, Man Yuan, 2022, Frontiers in Oncology.

Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth

N. Xu, Y. Lao, Qianjun Zhou, 2018, Cell Death & Disease.

SRC and MEK Co-inhibition Synergistically Enhances the Anti-tumor Effect in Both Non-small-cell Lung Cancer (NSCLC) and Erlotinib-Resistant NSCLC

Y. Lao, Hua Zhou, Man Wu, 2019, Front. Oncol..

Gambogenic acid inhibits fibroblast growth factor receptor signaling pathway in erlotinib-resistant non-small-cell lung cancer and suppresses patient-derived xenograft growth

N. Xu, Y. Lao, Qianjun Zhou, 2018, Cell Death & Disease.